Routine H&E Histology Encodes Postoperative Risk Heterogeneity in Resected Pancreatic Ductal Adenocarcinoma: A Multicohort Evaluation of TIGERS.

IF 6.6 1区 医学 Q1 PATHOLOGY
Yixuan Shen, Chengwei Chen, Hui Jiang, Wenbin Liu, Yunshuo Zhang, Yelin Yang, Ming Yang, Danqun Zheng, Jieyu Yu, Fang Liu, Jing Li, Yilun Zheng, Xiaomu Hu, Jianping Lu, Chengwei Shao, Yun Bian
{"title":"Routine H&E Histology Encodes Postoperative Risk Heterogeneity in Resected Pancreatic Ductal Adenocarcinoma: A Multicohort Evaluation of TIGERS.","authors":"Yixuan Shen, Chengwei Chen, Hui Jiang, Wenbin Liu, Yunshuo Zhang, Yelin Yang, Ming Yang, Danqun Zheng, Jieyu Yu, Fang Liu, Jing Li, Yilun Zheng, Xiaomu Hu, Jianping Lu, Chengwei Shao, Yun Bian","doi":"10.1016/j.modpat.2026.101099","DOIUrl":null,"url":null,"abstract":"<p><p>Patients with resected pancreatic ductal adenocarcinoma (PDAC) can have different outcomes despite similar TNM stage. We developed TIGERS (Tumor Intelligence Grading and Evaluation Risk Score), a nine-feature prognostic biomarker derived from routine hematoxylin and eosin (H&E) whole-slide images. TIGERS quantifies tumor burden, glandular and nuclear morphology, chromatin texture, and tumor-stroma topology. The score was trained in 644 treatment-naive cases and evaluated in an internal validation cohort (n = 385), a separate post-neoadjuvant cohort (n = 275), two external cohorts (n = 260 and n = 235), the TCGA-PAAD cohort (n = 133), and a prospectively accrued external cohort (n = 155) with subsequent offline inference. Overall survival was the primary endpoint; the same formula and locked cutoff were applied throughout. The cutoff stratified survival in the internal validation cohort and three of four retrospective test cohorts. In the remaining external cohort, 226 of 235 patients (96.2%) were classified as high risk, showing limited transportability of the fixed threshold. Adding TIGERS to the clinicopathologic model increased Harrell's C-index in all six retrospective cohorts (range 0.015-0.047). In the prospectively accrued cohort, mortality was 47.5% in the high-risk group and 22.7% in the low-risk group; high risk remained associated with worse survival after adjustment (hazard ratio, 4.45; 95% confidence interval, 2.28-8.70; P < .001). Automated quality control passed 92.3% of screened cases, and scoring was completed in all included cases with a median turnaround time of 13.5 minutes. TIGERS assigned 43.2% of patients to a different risk category than the prespecified stage-based definition. Higher TIGERS correlated with a more basal-like proteomic profile in both the training and internal validation cohorts, supporting a molecular basis for its prognostic value. Routine H&E histology may therefore provide prognostic information complementary to conventional clinicopathologic assessment. Prospective interventional studies are needed before TIGERS can guide treatment or surveillance.</p>","PeriodicalId":18706,"journal":{"name":"Modern Pathology","volume":" ","pages":"101099"},"PeriodicalIF":6.6000,"publicationDate":"2026-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Modern Pathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.modpat.2026.101099","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Patients with resected pancreatic ductal adenocarcinoma (PDAC) can have different outcomes despite similar TNM stage. We developed TIGERS (Tumor Intelligence Grading and Evaluation Risk Score), a nine-feature prognostic biomarker derived from routine hematoxylin and eosin (H&E) whole-slide images. TIGERS quantifies tumor burden, glandular and nuclear morphology, chromatin texture, and tumor-stroma topology. The score was trained in 644 treatment-naive cases and evaluated in an internal validation cohort (n = 385), a separate post-neoadjuvant cohort (n = 275), two external cohorts (n = 260 and n = 235), the TCGA-PAAD cohort (n = 133), and a prospectively accrued external cohort (n = 155) with subsequent offline inference. Overall survival was the primary endpoint; the same formula and locked cutoff were applied throughout. The cutoff stratified survival in the internal validation cohort and three of four retrospective test cohorts. In the remaining external cohort, 226 of 235 patients (96.2%) were classified as high risk, showing limited transportability of the fixed threshold. Adding TIGERS to the clinicopathologic model increased Harrell's C-index in all six retrospective cohorts (range 0.015-0.047). In the prospectively accrued cohort, mortality was 47.5% in the high-risk group and 22.7% in the low-risk group; high risk remained associated with worse survival after adjustment (hazard ratio, 4.45; 95% confidence interval, 2.28-8.70; P < .001). Automated quality control passed 92.3% of screened cases, and scoring was completed in all included cases with a median turnaround time of 13.5 minutes. TIGERS assigned 43.2% of patients to a different risk category than the prespecified stage-based definition. Higher TIGERS correlated with a more basal-like proteomic profile in both the training and internal validation cohorts, supporting a molecular basis for its prognostic value. Routine H&E histology may therefore provide prognostic information complementary to conventional clinicopathologic assessment. Prospective interventional studies are needed before TIGERS can guide treatment or surveillance.

常规H&E组织学编码切除胰腺导管腺癌术后风险异质性:tiger的多队列评估。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Modern Pathology
Modern Pathology 医学-病理学
CiteScore
14.30
自引率
2.70%
发文量
174
审稿时长
18 days
期刊介绍: Modern Pathology, an international journal under the ownership of The United States & Canadian Academy of Pathology (USCAP), serves as an authoritative platform for publishing top-tier clinical and translational research studies in pathology. Original manuscripts are the primary focus of Modern Pathology, complemented by impactful editorials, reviews, and practice guidelines covering all facets of precision diagnostics in human pathology. The journal's scope includes advancements in molecular diagnostics and genomic classifications of diseases, breakthroughs in immune-oncology, computational science, applied bioinformatics, and digital pathology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书